Molecular markers that have been identified in prognosis and risk of relapse in localized prostate cancer.

Dr. Robert Bristow, MD of Princess Margaret Cancer Centre discusses molecular markers that have been identified in prognosis and risk of relapse in localized prostate cancer at ASCO GU 2016